[SCHEDULE 13G] Semler Scientific, Inc. Passive Investment Disclosure (>5%)
Weiss Asset Management Reports 5.2% in Semler
Semler Scientific, Inc. shareholder Weiss Asset Management LP reported beneficial ownership of 801,086 shares of common stock, representing 5.2% of the class.
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Semler Scientific, Inc. shareholder Weiss Asset Management LP reported beneficial ownership of 801,086 shares of common stock, representing 5.2% of the class. This percentage is based on 15,285,092 shares outstanding as of November 19, 2025, as reported in the issuer’s Schedule 14A.
Weiss Asset Management, GP LLC, and Andrew M. Weiss report shared voting and dispositive power over 801,086 shares, with no sole voting or dispositive power. They state the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Semler Scientific.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in Semler Scientific (SMLR) did Weiss Asset Management report?
Weiss Asset Management reported beneficial ownership of 801,086 Semler Scientific shares, equal to 5.2% of the common stock. This stake reflects institutional holdings managed for a partnership and funds, with shared voting and dispositive power over the reported shares.
How was the 5.2% ownership in Semler Scientific (SMLR) calculated?
The 5.2% figure comes from 801,086 shares beneficially owned out of 15,285,092 Semler common shares outstanding. The outstanding share count is taken from Semler’s Schedule 14A, which reported that total as of November 19, 2025, and was referenced in this ownership filing.
Who are the reporting persons in this Semler Scientific (SMLR) Schedule 13G?
The filing lists three reporting persons: Weiss Asset Management LP, GP LLC, and Andrew M. Weiss, Ph.D. They report the same 801,086 shares with shared voting and dispositive power, and each disclaims beneficial ownership beyond any pecuniary interest in those securities.
Does Weiss Asset Management seek control of Semler Scientific (SMLR) with this 5.2% stake?
The filing states the securities were acquired and are held in the ordinary course of business, not to change or influence control of Semler Scientific. It also notes they are not held in connection with any control-related transaction, other than specified proxy nomination activities under SEC rules.
What voting and dispositive powers are reported over Semler Scientific (SMLR) shares?
The reporting persons indicate no sole voting or dispositive power over Semler shares. Instead, they report shared voting power over 801,086 shares and shared dispositive power over the same amount, reflecting coordinated management of these holdings across related investment entities.
When did the ownership event for this Semler Scientific (SMLR) Schedule 13G occur?
The date of the event triggering this Schedule 13G is December 31, 2025. That date reflects when the reporting persons’ beneficial ownership position met the threshold requiring public disclosure under SEC rules for significant institutional shareholders.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Semler Scientific, Inc.
(Name of Issuer)
Common Stock, $0.001 par value per share
(Title of Class of Securities)
81684M104
(CUSIP Number)
12/31/2025
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
81684M104
1
Names of Reporting Persons
Weiss Asset Management LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
801,086.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
801,086.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
801,086.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.2 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP No.
81684M104
1
Names of Reporting Persons
WAM GP LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
801,086.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
801,086.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
801,086.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.2 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
CUSIP No.
81684M104
1
Names of Reporting Persons
WEISS ANDREW M
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
801,086.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
801,086.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
801,086.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.2 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Semler Scientific, Inc.
(b)
Address of issuer's principal executive offices:
51 E CAMPBELL AVE, SUITE 107-D, CAMPBELL, CALIFORNIA, 95008.
Item 2.
(a)
Name of person filing:
(i) Weiss Asset Management LP ("Weiss Asset Management").
(ii) WAM GP LLC ("WAM GP").
(iii) Andrew M. Weiss, Ph.D. ("Andrew Weiss").
(b)
Address or principal business office or, if none, residence:
Weiss Asset Management, WAM GP, and Andrew Weiss have a business address of 222 Berkeley St., 16th Floor, Boston, Massachusetts 02116.
(c)
Citizenship:
(i) Weiss Asset Management is a Delaware limited partnership.
(ii) WAM GP is a Delaware limited liability company.
(iii) Andrew Weiss is a United States citizen
(d)
Title of class of securities:
Common Stock, $0.001 par value per share
(e)
CUSIP No.:
81684M104
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
801,086
Weiss Asset Management is the sole investment manager to a private investment partnership, (the "Partnership") and private investment funds ("Funds"). WAM GP is the sole general partner of Weiss Asset Management. Andrew Weiss is the managing member of WAM GP. Shares reported for WAM GP, Andrew Weiss and Weiss Asset Management include shares beneficially owned by the Partnership and the Funds.
Each of WAM GP, Weiss Asset Management, and Andrew Weiss disclaims beneficial ownership of the shares reported herein as beneficially owned by each except to the extent of their respective pecuniary interest therein. The percent of class computations are based on 15,285,092 shares of Common Stock, $0.001 par value per share, as of November 19, 2025, as reported in the Form Schedule 14A of the Issuer, which was filed with the SEC on December 5, 2025.
(b)
Percent of class:
5.2%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
801,086
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
801,086
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See Item 4.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Weiss Asset Management LP
Signature:
Mary Merrigan
Name/Title:
Authorized Signatory
Date:
02/11/2026
WAM GP LLC
Signature:
Mary Merrigan
Name/Title:
Authorized Signatory
Date:
02/11/2026
WEISS ANDREW M
Signature:
Mary Merrigan
Name/Title:
Attorney-in-Fact for Andrew M. Weiss***
Date:
02/11/2026
Comments accompanying signature: ***Duly authorized under Power of Attorney incorporated herein by reference to the exhibit to the Form 13G/A filed by Weiss Asset Management LP on February 3, 2023 in respect of its holding in DEEP MEDICINE ACQUISITION CORP.
